Liver Fibrosis Panel Test in UAE | 210 AED | DHA Guidelines

Executive Summary & Core Metrics

✓ Accuracy Assurance: 99.9% diagnostic sensitivity via ISO 9001:2015 certified processing.
✓ Premium Home Service: Hospital-grade blood draw at home through ISO certified cold-chain and VIP mobile phlebotomy.
✓ Medical Guidance: Post-test telephonic consultation to interpret results.
✓ Insurance Verification: Direct coverage check via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Liver Fibrosis Panel is a comprehensive, non-invasive blood test that combines markers of hepatic synthesis, coagulation, and fibrogenesis to stage liver scarring without biopsy. This panel offers same-day results and physician-led interpretation, enabling early intervention for conditions such as fatty liver, hepatitis, and unexplained enzyme elevations.

Feature	Our Test (DNA Labs UAE)	Standard Hospital Panel
Precision & Methodology	Spectrophotometry, Electromechanical Clot Detection, Capillary Electrophoresis – multiparametric algorithm with high sensitivity for early fibrosis.	Single‑platform spectrophotometry; may miss early coagulopathy.
Turnaround Time	Same‑day reporting (sample received by 9 AM).	24–72 hours.
Physician Interpretation	Included telephonic post‑test clinical guidance by DHA‑licensed specialists.	Report only; consultation extra.

Physician Insight & Safety Protocols

“The liver is remarkably resilient, yet fibrosis can progress silently. This panel gives you a quantitative snapshot of hepatic health without invasive biopsy. Use the results as a guide, not a diagnosis—always discuss with your treating physician for a complete clinical context.” – Dr. Ajay Singh, General Practitioner, DHA License: 36234132

Important Medication Advisory

If you are currently taking anticoagulants (e.g., warfarin, heparin, rivaroxaban), do not stop or alter your medication without explicit instructions from your prescribing physician. Your doctor may recommend a temporary pause only after a thorough risk-benefit assessment. Always follow their guidance precisely.

Exclusion Criteria & Emergency Red Flags

Active bleeding, recent major surgery, or acute thrombosis – do not collect sample; seek emergency care.
Signs of acute liver failure: sudden jaundice, confusion, severe abdominal swelling – report to ER immediately.
Pregnancy beyond first trimester if coagulation-related markers are requested without obstetric clearance.
Known hypersensitivity to venipuncture materials; inform phlebotomist before collection.

Patient FAQ & Clinical Guidance

1. What does the Liver Fibrosis Panel measure, and when should I take it?

Answer: This panel evaluates liver scarring through blood markers for synthesis, clotting, and fibrosis—providing a non‑invasive alternative to biopsy for patients with fatty liver, hepatitis, or unexplained liver enzyme elevation.

2. How do I prepare for the test? Are there medications I need to stop?

Answer: Overnight fasting is preferred; your doctor may instruct you to pause heparin for 1 day or oral blood thinners for 7 days—only after a careful risk assessment and never without explicit medical consent.

3. When will I receive results, and will I get a clinical interpretation?

Answer: Results are reported the same day if the sample reaches the lab by 9 AM, and our DHA‑licensed general practitioner provides a complimentary telephonic interpretation to help you understand the next steps.

UAE Regulatory & Data Privacy Adherence

Compliance Framework

Data Protection: Subject to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Medical Liability: Patient safety and consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Laboratory Certification: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).

Clinical & Logistical Metadata

Test Name	Liver Fibrosis Panel
Price (AED)	210
Turnaround Time	Same-day (sample received by 9 AM)
Sample Type / Matrix	Peripheral whole blood (serum/plasma)
Methodology Used	Spectrophotometry, Electromechanical Clot Detection, Capillary Electrophoresis
ICD-10-CM Code	K74.0 (Hepatic fibrosis)
LOINC Code	24324-8 (Hepatic fibrosis panel)
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE